Twist Bioscience Corp (TWST) — Cash Flow-to-Debt Ratio
Twist Bioscience Corp (TWST) has a Cash Flow-to-Debt Ratio of -0.08x as of March 2026, meaning its operating cash flow of $-17.56 Million could theoretically repay 0% of its total liabilities ($221.12 Million) in one year. Explore investment intensity of Twist Bioscience Corp to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Twist Bioscience Corp Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Twist Bioscience Corp across 10 annual periods. Also explore TWST asset base for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Twist Bioscience Corp (2016–2025)
Year-by-year debt coverage analysis for Twist Bioscience Corp. For market capitalisation and broader financial context, see TWST stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.28x | $-47.63 Million | $168.90 Million | ▲ +37.7% |
| 2024 | -0.45x | $-64.09 Million | $141.63 Million | ▲ +51.4% |
| 2023 | -0.93x | $-142.47 Million | $152.97 Million | ▼ -28.8% |
| 2022 | -0.72x | $-124.39 Million | $171.99 Million | ▲ +21.9% |
| 2021 | -0.93x | $-112.24 Million | $121.28 Million | ▲ +59.3% |
| 2020 | -2.27x | $-142.25 Million | $62.62 Million | ▲ +9.8% |
| 2019 | -2.52x | $-87.94 Million | $34.91 Million | ▼ -1107.6% |
| 2018 | -0.21x | $-66.16 Million | $317.21 Million | ▲ +11.0% |
| 2017 | -0.23x | $-51.30 Million | $219.01 Million | ▲ +7.1% |
| 2016 | -0.25x | $-38.59 Million | $153.07 Million | — |